Consensus of Expert Recommendations for the Safe Administration of Brolucizumab in Neovascular Age-related Macular Degeneration
Sign Up to like & getrecommendations! Published in 2025 at "Korean Journal of Ophthalmology : KJO"
DOI: 10.3341/kjo.2025.0010
Abstract: Brolucizumab offers improved anatomical outcomes and extended dosing intervals compared to aflibercept, reducing treatment burden. However, postmarketing surveillance and real-world studies have highlighted safety concerns, including intraocular inflammation (IOI), retinal vasculitis, and retinal vascular occlusion,… read more here.
Keywords: consensus; administration brolucizumab; safe administration; neovascular age ... See more keywords